Health Policy Fact Sheet（卫生政策简报）.pdfVIP

Health Policy Fact Sheet May 2015 Missed Opportunity? Twenty Percent of Breast Cancer Patients Don’t Know Their Recurrence Risk Status Alimat Adebiyi, BA, Catherine Chanfreau, PhD, Jennifer Haas, MD, Ninez Ponce, PhD SUMMARY: According to the recent study whether she is at high or low risk for cancer Empowering Choices in Breast Cancer recurrence, pointing to the need for better Treatment, one of every five women with communication between doctors and early-stage breast cancer does not know patients about genomic test results. ne in eight women will be diagnosed The Empowering Choices in Breast Cancer Owith breast cancer over her lifetime. Treatment study was led by the UCLA Together with their doctors, women with early Center for Health Policy Research in stage breast cancer that is estrogen receptor collaboration with Harvard University’s positive and lymph node negative must Brigham and Women’s Hospital and make the important decision of whether to Aetna. Voluntary participants in the include chemotherapy in their treatment plan. survey were Aetna health plan members, Determining the benefits of chemotherapy in female, and less than 65 years of age. All an individual case can be informed by gene had received the GEP test during breast expression profiling (GEP). This fact sheet cancer treatment between 2009 and 2012. reports findings from a new patient survey on how women’s decisions about their breast cancer Among the findings: treatment are influenced by GEP technology. Doctors are the main source of GEP information. GEP can help determine a patient’s risk of The majority (60 percent) of patients first the recurrence of breast cancer. Assessing learned about th